Production and characterization of monoclonal antibodies against human ceruloplasmin

Journal of Biochemistry and Molecular Biology

Volumn 38, Issue 1, 2005, Pages 71-76

  Won, Sik Eum ^a   Hee, Soon Choi ^a   Dae, Won Kim ^a   Sang, Ho Jang ^a   Soo, Hyun Choi ^a   So, Young Kim ^a   Park, Jinseu ^a   Jung, Hoon Kang ^b   Cho, Sung Woo ^c   Kwon, Oh Shin ^d   In, Koo Hwang ^a   Yoo, Ki Yeon ^a   Kang, Tae Cheon ^a   Moo, Ho Won ^a   Soo, Young Choi ^a  

^a Hallym University   (South Korea)

^b Chongju University   (South Korea)

^c University of Ulsan College of Medicine   (South Korea)

^d Kyungpook National University   (South Korea)

Author keywords

Antioxidants; Human ceruloplasmin; Monoclonal antibodies

Indexed keywords

AVES; MAMMALIA;

CERULOPLASMIN; MONOCLONAL ANTIBODY; PEPTIDE FRAGMENT;

ANIMAL; ARTICLE; BAGG ALBINO MOUSE; BRAIN; CAT; CATTLE; CELL LINE; CHICKEN; CROSS REACTION; DOG; EPITOPE MAPPING; FEMALE; HUMAN; HYBRIDOMA; IMMUNOBLOTTING; IMMUNOLOGY; ISOLATION AND PURIFICATION; METABOLISM; MOUSE; RAT; TISSUE DISTRIBUTION; WESTERN BLOTTING;

ANIMALS; ANTIBODIES, MONOCLONAL; BLOTTING, WESTERN; BRAIN; CATS; CATTLE; CELL LINE; CERULOPLASMIN; CHICKENS; CROSS REACTIONS; DOGS; EPITOPE MAPPING; FEMALE; HUMANS; HYBRIDOMAS; IMMUNOBLOTTING; MICE; MICE, INBRED BALB C; PEPTIDE FRAGMENTS; RATS; TISSUE DISTRIBUTION;

EID: 21244463543     PISSN: 12258687     EISSN: 12258687     Source Type: Journal    
DOI: None     Document Type: Article

References (23)

1. Aouffen, M., Paquin, J., De Grandpré, E., Nadeau, R. and Mateescu, M. A. (2001) Deglycosylated ceruloplasmin maintains its enzymatic, antioxidant, cardioprotective, and neuroprotective properties. Biochem. Cell Biol. 79, 489-497.
2. Choi, S. Y., Kwon, H. Y., Kwon, O. B., Eum, W. S. and Kang, J. H. (2000) Fragmentation of human ceruloplasmin induced by hydrogen peroxide. Biochimie 82, 175-180.
3. Choi, E. Y., Park, S. Y., Jang, S. H., Song, M. S., Cho, S. W. and Choi, S. Y. (1995) Production and characterization of monoclonal antibodies to bovine brain succinic semialdehyde reductase. J. Neurochem. 64, 371-377.
4. Choi, E. Y., Jang, S. H. and Choi, S. Y. (1996) Human brain GABA transaminase is immunologically distinct from those of other mammalian brain. Neurochem. Int. 28, 597-600.
5. Culotta, V. C. and Gitlin, J. D. (2001) Disorders of copper transport; in The Metabolic Basis of Inheritd Disease, Scrier, C. R., Beaudet, A. L., Sly, W. S. and Valle, D. (eds.), pp. 3105-3126, McGraw Hill, New York, USA.
6. Danks, D. M. (1989) Disorders of copper transport; in The Metabolic Basis of Inheritd Disease, Scrier, C. R., Beaudet, A. L., Sly, W. S. and Valle, D. (eds.), pp. 1411-1431, McGraw Hill, New York, USA.
7. Eum, W. S. and Kang, J. H. (1999) Release of copper ions from the familial amyotrophic lateral sclerosis-associated Cu,Zn-superoxide dismutase mutants. Mol. Cells 9, 110-114.
8. Fleming, R. E. and Gitlin, J. D. (1990) Primary structure of rat ceruloplasmin and analysis of tissue-specific gene expression during development. J. Biol. Chem. 265, 7701-7707.
9. Fleming, R. E., Whitman, I. P. and Gitlin, J. D. (1991) Induction of ceruloplasmin gene expression in rat lung during inflammation and hyperoxida. Am. J. Physiol. 260, 68-74.
10. Gitlin, J. D. (1988) Transcriptional regulation of ceruloplasmin gene expression during inflammation. J. Biol. Chem. 263, 6281-6287.
11. Irigoyen Oyarzabal, A. M., Amiguet Garicia, J. A., Lopez Vivaco, G., Genolla Subirats, J., Munoz Villafranca, M. C., Ojembarrena Martinez, E. and Liso Irurzun, P. (2003) Tumoral markers and acute-phase reactants in the diagnosis of pancreatic cancer. Gastroenterol. Hepatol. 26, 624-629.
12. Kang, J. H., Kim, K. S., Choi, S. Y., Kwon, H. Y., Won, M. H. and Kang, T. C. (2002) Protection by carnosine-related dipeptides against hydrogen peroxide-mediated ceruloplasmin modification. Mol. Cells 13, 107-112.
13. Lee, H. Y., Eum, W. S., Kim, D. W., Lee, B. R., Yoon, C. S., Jang, S. H., Choi, H. S., Choi, S. H., Back, N.-I., Kang, J. H., Kang, T.-C., Won, M. H., Cho, S.-W., Lee, K. S., Park, J. and Choi, S. Y. (2003) Isolation and identification of antioxidant enzyme catalase stimulatory compound from Garnoderma lucidum. J. Biochem. Mol. Biol. 36, 450-455.
14. Lee, Y. and Song, K. B. (2002) Effects of γ-irradiation on the molecular properties of myoglobin. J. Biochem. Mol. Biol. 35, 590-594.
15. Mateescu, M. A., Chahine, R., Roger, S., Atanasiu, R., Yamaguchi, N., Nalumiére, G. and Nadeau, R. (1995) Protection of myocardial tissue against deleterious effects of oxygen free radicals by ceruloplasmin. Arzneim.-Forsch. 45, 476-480.
16. Nayak, S. B., Bhat, V. R., Upadhyay, D. and Udupa, S. L. (2003) Copper and ceruloplasmin status in serum of prostate and colon cancer patients. Indian J. Physiol. Pharmacol. 47, 108-110.
17. Osaki, S., Johnson, D. A. and Frieden, E. (1966) The possible significance of the ferrous oxidase activity of ceruloplasmin in normal human serum. J. Biol. Chem. 241, 2746-2751.
18. Ozyilkan, O., Baltali, E. and Kirazli, S. (2000) CA 15-3, ceruloplasmin and tissue polypeptide specific antigen as a tumour marker panel in breast cancer. East Afr. Med. J. 77, 291-294.
19. Richardson, D. R. (1999) Role of ceruloplasmin and ascorbate in cellular iron release. J. Lab. Clin. Med. 13, 454-465.
20. Scheinberg, I. H. and Steinlieb, I. (1984) Ceruloplasmin; in Wilson Disease, Lloyd, H. and Smith, Jr. (eds.), pp. 1-171, W. B. Saunders Co., Philadelphia, USA.
21. Shulman, H., Wilde, C. D. and Kohler, G. (1978) A better cell line for making hybridomas secreting specific antibodies, Nature 276, 269-270.
22. Sunderman, F. W. Jr. and Nomoto, S. (1970) Measurement of human serum ceruloplasmin by its p-phenylenediamine oxidase activity. Clin. Chem. 16, 903-910.
23. Swain, J. A., Darley-Usmar, V. and Gutteridge, J. M. (1994) Peroxynitrite release copper from ceruloplasmin: implications for atherosclerosis. FEBS Lett. 342, 49-52.